Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: A case report

BACKGROUND: Anti-programmed cell death 1 antibody nivolumab is a promising agent for various cancers. Immune-related adverse events are recognized; however, bi-cytopenia with nivolumab has not been reported. CASE PRESENTATION: A 73-year-old man was diagnosed with advanced primary malignant melanoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Inadomi, Kyoko, Kumagai, Hozumi, Arita, Shuji, Tsuruta, Nobuhiro, Takayoshi, Kotoe, Mishima, Koji, Ota, Shun-Ichiro, Tanaka, Mamoru, Okumura, Yuta, Sagara, Kosuke, Nio, Kenta, Nakano, Michitaka, Uchi, Hiroshi, Yamamoto, Hidetaka, Ariyama, Hiroshi, Kusaba, Hitoshi, Niiro, Hiroaki, Oda, Yoshinao, Akashi, Koichi, Baba, Eishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265785/
https://www.ncbi.nlm.nih.gov/pubmed/27442668
http://dx.doi.org/10.1097/MD.0000000000004283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265785/
https://www.ncbi.nlm.nih.gov/pubmed/27442668
http://dx.doi.org/10.1097/MD.0000000000004283

Ejemplares similares